Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C
| Autor: | Avgi Mamalaki, Emmanuel Tsochatzis, George V. Papatheodoridis, E.K. Manesis, Georgia Kafiri, Athanasios J. Archimandritis, Vasiliki Koliaraki, Emilia Hadziyannis |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
medicine.medical_specialty
Cirrhosis Hepatology biology medicine.diagnostic_test nutritional and metabolic diseases Hepatitis C medicine.disease Gastroenterology Ferritin Infectious Diseases Blood serum Insulin resistance Hepcidin hemic and lymphatic diseases Virology Internal medicine Liver biopsy Immunology biology.protein medicine Viral hepatitis |
| Zdroj: | Journal of Viral Hepatitis. 17:800-806 |
| ISSN: | 1352-0504 |
| DOI: | 10.1111/j.1365-2893.2009.01244.x |
| Popis: | SUMMARY. Hepcidin is synthesized in the liver and has a crucial role in iron homoeostasis. Its synthesis is up-regulated in chronic inflammation and iron excess. We examined the determinants of serum hepcidin and liver hepcidin mRNA levels and their association with histological lesions in patients with chronic hepatitis C (CHC) and healthy controls. We studied 96 patients with CHC and 30 controls. Serum hepcidin levels were measured by an in-house competitive ELISA. Hepcidin mRNA levels were determined by a one-step qRT-PCR in total RNA extracted from liver biopsy specimens of 27 patients with CHC and six disease controls. Histological lesions were evaluated according to Ishaks classification. Serum hepcidin was significantly lower in patients with CHC than healthy controls (14.6 ± 7.3 vs 34.6 ± 17.3 ng/mL, P < 0.001). In patients with CHC, serum hepcidin correlated positively with aspartate aminotransferase (r = 0.334, P = 0.001) and insulin resistance (r = 0.27, P = 0.016) and had a trend for correlation with alanine aminotransferase (r = 0.197, P = 0.057) and serum haemoglobin (r = 0.188, P = 0.067) but not with ferritin. A significant positive correlation was also found between serum hepcidin levels and both necroinflammation (r = 0.259, P = 0.011) and fibrosis (r = 0.214, P = 0.036). Serum hepcidin was among others an independent predictor of cirrhosis (odds ratio: 1.145, P = 0.039). Liver hepcidin mRNA levels did not differ between patients and controls and were relatively lower in patients with than without cirrhosis (19.3 ± 21.7 vs 38.3 ± 26.0, P = 0.067). Patients with CHC have reduced serum hepcidin levels, which correlate with worse necroinflammation and fibrosis. The previously mentioned observations suggest a viral effect on hepatic hepcidin production, but might also support its involvement in the inflammatory process. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text